Table VI.
Association between MCM2 and TIP30 expression, clinicopathological characteristics and average survival of AC patients.
| Clinicopathological characteristics | Samples (n) | Average survival (month) | Chi-square | P-value |
|---|---|---|---|---|
| Sex | 2.567 | 0.109 | ||
| Male | 26 | 9.58 (3–24) | ||
| Female | 54 | 11.30 (3–24) | ||
| Age (years) | 0.003 | 0.956 | ||
| ≤45 | 16 | 10.81 (4–24) | ||
| >45 | 64 | 10.72 (3–24) | ||
| Differentiation | 32.501 | 0.000 | ||
| Well | 27 | 15.07 (5–24) | ||
| Moderately | 25 | 10.60 (4–24) | ||
| Poorly | 28 | 6.68 (3–14) | ||
| Tumor mass size | 68.283 | 0.000 | ||
| ≤3 cm | 50 | 13.70 (6–24) | ||
| >3 cm | 30 | 5.80 (3–10) | ||
| Gallstones | 0.246 | 0.620 | ||
| No | 42 | 10.19 (3–24) | ||
| Yes | 38 | 11.34 (4–24) | ||
| TNM stage | 105.825 | 0.000 | ||
| I+II | 21 | 18.96 (5–24) | ||
| III | 38 | 9.29 (6–15) | ||
| IV | 21 | 5.14 (3–7) | ||
| Lymph node metastasis | 42.372 | 0.000 | ||
| No | 30 | 16.27 (4–24) | ||
| Yes | 50 | 7.42 (3–14) | ||
| Invasion | 55.535 | 0.000 | ||
| No | 31 | 16.68 (7–24) | ||
| Yes | 49 | 6.98 (3–11) | ||
| Surgery | 113.141 | 0.000 | ||
| Radical | 26 | 18.31 (10–24) | ||
| Palliative | 28 | 8.64 (6–11) | ||
| Biopsy | 26 | 5.42 (3–9) | ||
| MCM2 | 11.466 | 0.001 | ||
| − | 37 | 13.24 (5–24) | ||
| + | 43 | 8.58 (3–24) | ||
| TIP30 | 6.894 | 0.009 | ||
| − | 41 | 8.95 (3–24) | ||
| + | 39 | 12.62 (4–24) |
MCM2, minichromosome maintenance complex component 2; TIP30, HIV-1 tat interactive protein 2; AC, adenocarcinoma.